Skip to main content

Penumbra Inc (PEN) Stock

Penumbra Inc Stock Details, Movements and Public Alerts

Stock Details

Penumbra Inc (PEN), a prominent company in the healthcare sector within the medical devices industry, is based in USA and primarily trades on the NYSE.Currently, the stock is trading at $336.01. Over the past 52 weeks, it has ranged between $221.26 and $362.41. This places the current price at 92.7% of its 52-week high and 51.9% above its 52-week low. Recent trading volume was recorded at 340,874. The 14-day Relative Strength Index (RSI) stands at 51.08, suggesting neutral conditions. The stock is currently trading below its 50-day moving average of $336.46 by 0.13%. Similarly, it is above its 200-day moving average of $279.96 by 20.02%. The MACD histogram is -0.71, indicating bearish momentum (MACD Line: 0.75, Signal Line: 1.45). There are currently 2 active alerts set for PEN by users.

52-Week Range

$362.41 - $221.26

-7.28% from high · +51.86% from low

Avg Daily Volume

753,763

20-day average

100-day avg: 780,915

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

75.25

Above market average

Forward P/E

66.23

Earnings expected to grow

PEG Ratio

0.77

Potentially undervalued

Price to Book

9.36

EV/EBITDA

58.25

EPS (TTM)

$4.50

Price to Sales

9.47

Beta

0.84

Less volatile than market

Q:How is PEN valued relative to its earnings and growth?
Penumbra Inc trades at a P/E ratio of 75.25, which is above the market average of approximately 20. This premium valuation suggests investors expect above-average growth or the company has competitive advantages justifying the higher multiple. Looking ahead, the forward P/E of 66.23 is lower than the current P/E, indicating analysts expect earnings to grow over the next year. The PEG ratio of 0.77 suggests the stock may be undervalued relative to its growth rate.
Q:What is PEN's risk profile compared to the market?
With a beta of 0.84, Penumbra Inc is less volatile than the overall market. This means when the market moves up or down by 10%, this stock typically moves less than 10% in the same direction. Lower beta stocks are often preferred by conservative investors seeking stability. The price-to-book ratio of 9.36 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Performance & Growth

Profit Margin

12.70%

Operating Margin

15.40%

EBITDA

$206.52M

Return on Equity

13.80%

Return on Assets

7.04%

Revenue Growth (YoY)

22.10%

Earnings Growth (YoY)

38.30%

Q:How profitable and efficient is PEN's business model?
Penumbra Inc achieves a profit margin of 12.70%, meaning it retains $12.70 from every $100 in revenue after all expenses. This represents a solid margin typical of well-run businesses, showing the company can effectively balance revenue generation with cost control. The operating margin of 15.40% reveals how efficiently the company runs its core business operations before interest and taxes. With ROE at 13.80% and ROA at 7.04%, the company achieves moderate returns on invested capital.
Q:What are PEN's recent growth trends?
Penumbra Inc's revenue grew by 22.10% year-over-year, representing robust expansion that significantly outpaces typical market growth rates. This strong top-line performance suggests the company is successfully capturing market share or benefiting from favorable industry trends. Earnings increased by 38.30% year-over-year, outpacing revenue growth through improved margins. These growth metrics should be evaluated against MEDICAL DEVICES industry averages for proper context.

Company Size & Market

Market Cap

$13.3B

Revenue (TTM)

$1.40B

Revenue/Share (TTM)

$36.07

Shares Outstanding

39.24M

Book Value/Share

$36.39

Asset Type

Common Stock

Q:What is PEN's market capitalization and position?
Penumbra Inc has a market capitalization of $13.3B, classifying it as a large-cap stock ($10B-$200B). Large-caps are typically industry leaders with established business models, offering a balance of stability and growth potential. They often provide dividend income and are core holdings in institutional portfolios. With 39.24M shares outstanding, the company's ownership is relatively concentrated. As a participant in the MEDICAL DEVICES industry, it competes with other firms in this sector.
Q:How does PEN's price compare to its book value?
Penumbra Inc's book value per share is $36.39, while the current stock price is $336.01, resulting in a price-to-book (P/B) ratio of 9.23. This high P/B ratio indicates significant intangible assets, strong brand value, or high growth expectations. Technology and consumer brand companies often trade at elevated P/B ratios due to intellectual property and competitive advantages not reflected on the balance sheet. As a common stock, this represents equity ownership with voting rights.

Analyst Ratings

Analyst Target Price

$360.13

7.18% upside potential

Analyst Recommendations

Strong Buy

2

Buy

2

Hold

14

Sell

0

Strong Sell

0

Q:How reliable are analyst predictions for PEN?
18 analysts cover PEN with 22% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The bearish sentiment could create opportunity if analysts are wrong. The consensus target of $360.13 implies 7.2% upside, but targets are often adjusted to follow price moves rather than predict them.
Q:What is the Wall Street consensus on PEN?
Current analyst recommendations:2 Strong Buy, 2 Buy, 14 Hold, 00The neutral stance suggests uncertainty or fair valuation at current levels.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Mar 8, 2026, 02:49 AM

Technical Indicators

RSI (14-day)

51.08

Neutral

50-Day Moving Average

$336.46

-0.13% below MA-50

200-Day Moving Average

$279.96

20.02% above MA-200

MACD Line

0.75

MACD Signal

1.45

MACD Histogram

-0.71

Bearish

Q:What does PEN's RSI value tell investors?
The RSI (Relative Strength Index) for PEN is currently 51.08, indicating the stock is in neutral territory (40-60 range). Neither buyers nor sellers have clear control, suggesting consolidation or balanced market forces. Combined with the price being below the 50-day moving average, this shows mixed signals requiring careful analysis.
Q:How should traders interpret PEN's MACD and moving average crossovers?
MACD analysis shows the MACD line at 0.75 below the signal line at 1.45, with histogram at -0.71. This bearish crossover indicates downward pressure. The 50-day MA ($336.46) is above the 200-day MA ($279.96), forming a golden cross pattern that typically signals a long-term uptrend. Price is currently between the MAs, suggesting transition.

Indicators last updated: Mar 6, 2026, 12:38 AM

Active Alerts

Alert Condition
Forward P/E falls below
Threshold
56.67 x
Created
Mar 5, 2026, 10:26 AM
Alert Condition
MA Breakout (Bearish)
Threshold
50 days
Created
Mar 5, 2026, 10:26 AM

Stay Ahead of the Market with Penumbra Inc Alerts

Set up price alerts for Penumbra Inc and get notified instantly when the price hits your target. Never miss an important price movement again.